 | Up a level |
2019
Jimenez-Andrade, E. F., Magnelli, B., Karim, A., Zamorani, G., Bondi, M., Schinnerer, E., Sargent, M., Romano-Diaz, E., Novak, M., Lang, P., Bertoldi, F., Vardoulaki, E., Toft, S., Smolcic, V., Harrington, K., Leslie, S., Delhaize, J., Liu, D., Karoumpis, C., Kartaltepe, J. and Koekemoer, A. M. (2019). Radio continuum size evolution of star-forming galaxies over 0.35 < z < 2.25. Astron. Astrophys., 625. LES ULIS CEDEX A: EDP SCIENCES S A. ISSN 1432-0746
2018
Bondi, M., Zamorani, G., Ciliegi, P., Smolcic, V, Schinnerer, E., Delvecchio, I, Jimenez-Andrade, E. F., Liu, D., Lang, P., Magnelli, B., Murphy, E. J. and Vardoulaki, E. (2018). Linear radio size evolution of mu Jy populations. Astron. Astrophys., 618. LES ULIS CEDEX A: EDP SCIENCES S A. ISSN 1432-0746
Kroener, A., Nagel, T. J., Hoffmann, J. E., Liu, X., Wong, J., Hegner, E., Xie, H., Kasper, U., Hofmann, A. and Liu, D. (2018). High-temperature metamorphism and crustal melting at ca. 3.2 Ga in the eastern Kaapvaal craton, southern Africa. Precambrian Res., 317. S. 101 - 117. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1872-7433
2017
Liu, L., Weiss, A., Perez-Beaupuits, J. P., Guesten, R., Liu, D., Gao, Y., Menten, K. M., van der Werf, P., Israel, F. P., Harris, A., Martin-Pintado, J., Requena-Torres, M. A. and Stutzki, J. (2017). HIFI Spectroscopy of H2O Submillimeter Lines in Nuclei of Actively Star-forming Galaxies. Astrophys. J., 846 (1). BRISTOL: IOP PUBLISHING LTD. ISSN 1538-4357
2016
Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih 
ORCID: 0000-0002-1172-8668, Fraser, Graeme, Silva, Rodrigo Santucci, Grosicki, Sebastian ORCID: 0000-0003-2644-1050, Pristupa, Aleksander, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Pylypenko, Halyna, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Villa, Diego, Samoilova, Olga, Panagiotidis, Panagiots, Goy, Andre ORCID: 0000-0001-5125-6522, Mato, Anthony, Pavlovsky, Miguel A., Karlsson, Claes, Mahler, Michelle, Salman, Mariya, Sun, Steven, Phelps, Charles, Balasubramanian, Sriram, Howes, Angela, Hallek, Michael, Assouline, S., Bence-Bruckler, I., Buckstein, R., Fraser, G., Larratt, L., Minuk, L., Villa, D., Angevine, A., Bartlett, N., Bixby, D., Caimi, P., Chanan-Khan, A., Craig, M., Forero-Torres, A., Ganguly, S., Goy, A., Heffner, L., Hermann, R., Lansigan, F., Leis, J., Letzer, J., Link, B., Liu, D., McCaul, K., McGuire, E., Skinner, W., Starodub, A., Stuart, R., Thirman, M., Tirumali, N., Yang, J., Janssens, A., Offner, F., Van den Neste, E., Van Hoof, A., Mayer, J., Novak, J., Trneny, M., Cartron, G., Dartigeas, C., Dilhuydy, M., Ghez, D., Haioun, C., Leblond, V., Salles, G., Balser, C., Cramer, P., Dreger, P., Durig, J., Eckart, M., Heinrich, B., Illmer, T., Jentsch-Ullrich, K., Pfreundschuh, M., Schetelig, J., Schlag, R., Soling, U., Stilgenbaue, S., Anagnostopoulos, A., Dimopoulos, A., Panagiotidis, P., Vrakidou, E., Bairey, O., Ben Yehuda, D., Braester, A., Fineman, R., Herishanu, Y., Nagler, A., Ruchlemer, R., Tadmor, T., Grosicki, S., Homenda, W., Jurczak, W., Pluta, A., Woszczyk, D., Espirito Santo, A., Luis, R., Raposo, J., Viveiros, C., Alexeeva, J., Dunaev, Y., Golubeva, M., Khuageva, N., Loginov, A., Lysenko, I., Osmanov, E., Pavlov, V., Pristupa, A., Proydakov, A., Rossiev, V., Samarina, I., Samoilova, O., Serduk, O., Shneider, T., Udovitsa, D., Voloshin, S., Gayoso, J., Gonzalez, M., Gonzalez Barca, E., Hernandez Rivas, J., Jargue, I., Loscertales, J., Karlsson, C., Sender, M., Aktan, M., Arslan, O., Demirkan, F., Ferhanoglu, B., Kaynar, L., Sayinalp, N., Vaural, F., Yagci, M., Dyagil, I., Kaplan, P., Masliak, Z., Oliynyk, H., Popovska, T., Pylypenko, H., Rekhtman, G., Dearden, C., Morley, N., Moss, P., Rule, S., Pavlovsky, M., Riveros, D., Santucci-Silva, R., Romeo, M., Scheliga, A., Salazar, L., Gomez, D., Ramirez, E. and Jung, C.
(2016).
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol., 17 (2).
S. 200 - 212.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488